Keeping Current CME podcast

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

0:00
38:19
Rewind 15 seconds
Fast Forward 15 seconds

See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes.

Credit available for this activity expires: 12/10/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

More episodes from "Keeping Current CME"